Activation of the PI3K-AKT-mTOR signaling is relevant to the escape of cancer cells from endocrine therapy by inhibiting the proapoptotic proteins and therefore contributes to endocrine resistance [46, 47]. The gene discussed is MTOR; the disease is cancer.